Pharmaceutical News

RSS

New computer-based approach can predict adverse reactions of drugs

Side effects are a major reason that drugs are taken off the market and a major reason why patients stop taking their medications, but scientists are now reporting the development of a new way to predict those adverse reactions ahead of time.

3 Jan 2013

Adrenomed creates Adrecizumab to decrease death rates from sepsis

The German corporation Adrenomed AG today announced its intentions to contribute to the reduction of mortality from sepsis and septic shock. Sepsis is an advanced systemic infection that travels via the blood stream to many of the body's vital organs, which can lead to death and disability.

3 Jan 2013

TFP5 molecule restores memory in mice with Alzheimer's

A new ray of hope has broken through the clouded outcomes associated with Alzheimer's disease. A new research report published in January 2013 print issue of the FASEB Journal by scientists from the National Institutes of Health shows that when a molecule called TFP5 is injected into mice with disease that is the equivalent of human Alzheimer's, symptoms are reversed and memory is restored-without obvious toxic side effects.

3 Jan 2013

Ineffective communication contributes to poor drug adherence

Even the best medicines in the world can be rendered ineffective if they are not taken as prescribed. The problem known as medication "non-adherence" is a major health issue in the United States, contributing to worse outcomes for people who have diabetes and other chronic diseases.

3 Jan 2013

FDA acknowledges resubmission of Merck’s NDA for ezetimibe and atorvastatin tablets

Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has acknowledged the resubmission of a New Drug Application (NDA) for ezetimibe and atorvastatin tablets, an investigational combination medicine.

3 Jan 2013

Banning thimerosal from vaccines could hinder achievements in global childhood immunization

"Thanks to a herculean effort by health advocates, 78 percent of children in low-income countries receive the basic set of childhood vaccines, covering diphtheria, tetanus, pertussis, hepatitis B and haemophilus influenza," a Bloomberg View editorial states.

3 Jan 2013

Salix receives FDA approval for crofelemer to treat HIV-associated diarrhea

On New Year's Eve of 2012, the US Food and Drug Administration (FDA) announced its approval of crofelemer (Fulyzaq, Salix Pharmaceuticals, Ltd., Raleigh, North Carolina) — marking the second time a botanical, and the first time an orally administered botanical, has received drug approval from the Administration.

3 Jan 2013

Bristol-Myers Squibb, Pfizer receive FDA approval for ELIQUIS to reduce risk of stroke and SE

Bristol-Myers Squibb Company and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) approved ELIQUIS (apixaban) to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.

2 Jan 2013

Crofelemer receives FDA approval for treatment of HIV associated diarrhea

Glenmark Pharmaceuticals Limited announced today that the US Food and Drug Administration has provided Marketing approval to its partner in US, Salix Pharmaceuticals Limited, for Crofelemer 125 mg delayed-release tablets for the symptomatic relief of non-infectious diarrhea in patients with human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome (AIDS) on anti-retroviral therapy (ART).

2 Jan 2013

No significant link between SSRI use during pregnancy and risk of stillbirth, neonatal death

In a study that included nearly 30,000 women from Nordic countries who had filled a selective serotonin reuptake inhibitor (SSRI) prescription during pregnancy, researchers found no significant association between use of these medications during pregnancy and risk of stillbirth, neonatal death, or postneonatal death, after accounting for factors including maternal psychiatric disease, according to a study in the January 2 issue of JAMA.

1 Jan 2013

Oral Eliquis receives FDA approval for treatment of clots in non-valvular atrial fibrillation patients

The U.S. Food and Drug Administration today approved the anti-clotting drug Eliquis (apixaban), an oral tablet used to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation that is not caused by a heart valve problem.

29 Dec 2012

Common cholesterol-lowering drug may help protect against cerebral malaria

Researchers have discovered that adding lovastatin, a widely used cholesterol-lowering drug, to traditional antimalarial treatment decreases neuroinflammation and protects against cognitive impairment in a mouse model of cerebral malaria.

29 Dec 2012

Genetic differences in enzyme CYP2D6 play a key role in effectiveness of tamoxifen for breast cancer

For nearly a decade, breast cancer researchers studying the hormone therapy tamoxifen have been divided as to whether genetic differences in a liver enzyme affect the drug's effectiveness and the likelihood breast cancer will recur.

27 Dec 2012

Study demonstrates safety of using tPA for stroke in community hospital settings

From the moment a stroke occurs, patients must race against the clock to get treatment that can prevent lasting damage. Now, a new study shows the promise – and the challenges – of getting them state-of-the-art treatment safely at their local hospital, saving precious minutes.

21 Dec 2012

CHPA praises signing into law of anti-methamphetamine bill

The Consumer Healthcare Products Association (CHPA) today applauded Ohio Governor John Kasich for signing into law House Bill 334, an anti-methamphetamine bill authored by Representative Terry Johnson (R-Portsmouth) and Representative Danny Bupb (R-West Union). With the new law, Ohio now becomes the 25th state to adopt real-time, stop-sale technology known as the National Precursor Log Exchange (NPLEx).

21 Dec 2012

House passes bio-threat vaccines, Medicare coverage bills

The House passed several health measures Wednesday including bills on developing vaccines to thwart bio-threats and on Medicare coverage for immune deficiency care.

21 Dec 2012

New low-cost combined therapy shows promise against malaria

Malaria brings misery and death to millions in the developing world each year, and fighting it keeps medical researchers up at night because the mosquito-borne parasite Plasmodium falciparum, which causes the deadliest form of the disease, has developed resistance to every drug thrown at it. Resistance has cut short the useful life of nearly every therapy tried so far, experts say.

21 Dec 2012

UAB research succeeds in testing a vaccine against leishmaniasis

A research coordinated by the UAB has succeeded in testing a vaccine against leishmaniasis. The vaccine was tested with the best animal model existing, the golden hamster, and can be produced at low costs by using insect larvae.

21 Dec 2012

FDA seeks input from states on drug compounders

FDA Commissioner Margaret Hamburg convened a meeting that included federal officials and representatives from state boards of pharmacy and governors' offices. Meanwhile, the Los Angeles Times reports on "rogue pharmacists."

21 Dec 2012

NPR, Inter Press Service examine efforts to prevent drug-resistant malaria

As part of its continuing coverage of malaria, NPR's "Shots" blog features a story on counterfeit anti-malarial drugs, which "are among the most popular drugs to fake." According to the blog, "These faux pharmaceuticals are particularly dangerous because malaria can kill a person in a matter of days," and, if the drugs contain only a small amount of the real drug, they can contribute to the development of drug-resistant malaria parasites.

21 Dec 2012

Pharmaceutical News

New computer-based approach can predict adverse reactions of drugs

Adrenomed creates Adrecizumab to decrease death rates from sepsis

TFP5 molecule restores memory in mice with Alzheimer's

Ineffective communication contributes to poor drug adherence

FDA acknowledges resubmission of Merck’s NDA for ezetimibe and atorvastatin tablets

Banning thimerosal from vaccines could hinder achievements in global childhood immunization

Salix receives FDA approval for crofelemer to treat HIV-associated diarrhea

Bristol-Myers Squibb, Pfizer receive FDA approval for ELIQUIS to reduce risk of stroke and SE

Crofelemer receives FDA approval for treatment of HIV associated diarrhea

No significant link between SSRI use during pregnancy and risk of stillbirth, neonatal death

Oral Eliquis receives FDA approval for treatment of clots in non-valvular atrial fibrillation patients

Common cholesterol-lowering drug may help protect against cerebral malaria

Genetic differences in enzyme CYP2D6 play a key role in effectiveness of tamoxifen for breast cancer

Study demonstrates safety of using tPA for stroke in community hospital settings

CHPA praises signing into law of anti-methamphetamine bill

House passes bio-threat vaccines, Medicare coverage bills

New low-cost combined therapy shows promise against malaria

UAB research succeeds in testing a vaccine against leishmaniasis

FDA seeks input from states on drug compounders

NPR, Inter Press Service examine efforts to prevent drug-resistant malaria

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News